FDA Approves First Treatment For COVID-19
The US FDA has approved the antiviral drug Veklury/Remdesivir for use in both adult and pediatric patients that are 12+ years of age and weigh at least 40kg/88lbs for the treatment of COVID-19 requiring hospitalization. However, it should only be administered in a hospital or in a healthcare setting that is capable of providing acute …